05/13/2025 10:44 AM | Allogene Therapeutics (Subject) Capital World Investors (Filed by)
| Form SCHEDULE 13G | |
05/09/2025 4:49 PM | Allogene Therapeutics (Subject) Chang David D (Filed by)
| Form SCHEDULE 13G/A | |
05/09/2025 4:30 PM | Allogene Therapeutics (Subject) Belldegrun Arie (Filed by)
| Form SCHEDULE 13G/A | |
04/23/2025 4:28 PM | Allogene Therapeutics (Issuer) Yoshiyama Annie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2025 3:49 PM | Allogene Therapeutics (Subject) Yoshiyama Annie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2025 8:35 AM | Allogene Therapeutics (Subject) BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
03/18/2025 4:28 PM | Allogene Therapeutics (Issuer) Beneski Benjamin Machinas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:30 PM | Allogene Therapeutics (Issuer) Chang David D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 9:01 AM | Allogene Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
03/05/2025 3:11 PM | Allogene Therapeutics (Issuer) Beneski Benjamin Machinas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:58 PM | Allogene Therapeutics (Issuer) Beneski Benjamin Machinas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for ALLO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
02/14/2025 8:02 AM | Allogene Therapeutics (Subject) Lynx1 Capital Management LP (Filed by)
| Form SCHEDULE 13G | |
02/05/2025 3:16 PM | Allogene Therapeutics (Issuer) Douglas Earl Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/03/2025 3:32 PM | Allogene Therapeutics (Subject) Roberts Zachary (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025 3:28 PM | Allogene Therapeutics (Subject) Parker Geoffrey M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 7:35 AM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/28/2025 7:10 PM | Allogene Therapeutics (Issuer) Chang David D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 7:11 PM | Allogene Therapeutics (Issuer) Belldegrun Arie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 7:13 PM | Allogene Therapeutics (Issuer) Roberts Zachary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 7:14 PM | Allogene Therapeutics (Issuer) Yoshiyama Annie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 7:15 PM | Allogene Therapeutics (Issuer) Parker Geoffrey M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 7:16 PM | Allogene Therapeutics (Issuer) Douglas Earl Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 3:30 PM | Allogene Therapeutics (Issuer) Roberts Zachary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 3:22 PM | Allogene Therapeutics (Subject) Roberts Zachary (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 3:53 PM | Allogene Therapeutics (Issuer) MESSEMER DEBORAH M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2024 1:15 PM | Allogene Therapeutics (Subject) Humer Franz B (Reporting)
| Form 144/A | |
12/02/2024 1:11 PM | Allogene Therapeutics (Subject) Humer Franz B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024 9:57 AM | Allogene Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/23/2024 3:21 PM | Allogene Therapeutics (Issuer) Parker Geoffrey M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/22/2024 2:24 PM | Allogene Therapeutics (Subject) BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
06/20/2024 3:31 PM | Allogene Therapeutics (Issuer) MESSEMER DEBORAH M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:33 PM | Allogene Therapeutics (Subject) MESSEMER DEBORAH M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024 3:30 PM | Allogene Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 4:28 PM | Allogene Therapeutics (Issuer) Kazam Joshua A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:29 PM | Allogene Therapeutics (Issuer) WITTE OWEN N. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:30 PM | Allogene Therapeutics (Issuer) Humer Franz B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:33 PM | Allogene Therapeutics (Issuer) SATO VICKI L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:34 PM | Allogene Therapeutics (Issuer) Barrett Elizabeth A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:35 PM | Allogene Therapeutics (Issuer) Mayo Stephen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:25 PM | Allogene Therapeutics (Issuer) MESSEMER DEBORAH M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:09 PM | Allogene Therapeutics (Issuer) Humer Franz B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Trump Predicts Dollar Downfall (Ad) READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry...
This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years."
Why Would He Say This? Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now. |
05/29/2024 1:08 PM | Allogene Therapeutics (Subject) Humer Franz B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |